Endocrine System Channel
Topics
Medications
Quicklinks
Related Channels

Drug Interactions With Insulin Aspart

Sulfonamide antibiotics, beta blockers, and disopyramide are some of the medications that may cause drug interactions with insulin aspart. Some interactions can increase blood sugar, while others can cause dangerously low blood sugar levels. To help prevent potentially life-threatening insulin aspart drug interactions, make sure to notify your healthcare provider any time you start, stop, or change the dose of any medication.

Insulin Aspart Drug Interactions: An Overview

Insulin aspart (NovoLog®) can potentially interact with several medications, too many to list entirely in this article. Some interactions (which are not discussed in this article) may increase blood sugar levels, which is not healthy but is usually not dangerous right away. Other insulin aspart drug interactions can result in dangerously low blood sugar levels (hypoglycemia), which can be life-threatening. Some of the medicines that may cause dangerously low blood sugar when combined with insulin aspart include:
 
  • Angiotensin-converting enzyme inhibitors (ACE inhibitors), such as:

 

 

 

 

 

 

  • Monoamine oxidase inhibitors (MAOIs), such as:

 

 

 

    • Aspirin (Ecotrin®, Bayer®, Anacin®)
    • Choline magnesium trisalicylate (Trilisate®)
    • Diflunisal (Dolobid®)
    • Salsalate (Salflex®, Disalcid®, Amigesic®)

 

  • Sulfonamide antibiotics ("sulfa drugs"), such as:

 

    • Sulfadiazine
    • Sulfadoxine (Fansidar®)
    • Sulfamethoxazole (Bactrim®, Septra®)
    • Sulfisoxazole (Gantrisin®)
 

 

Healthy Eating for People With Diabetes

Information on Insulin Aspart

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.